XML 98 R6.htm IDEA: XBRL DOCUMENT v3.24.4
Condensed Consolidated and Combined Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Cash Flows From Operating Activities:        
Net income (loss) $ (14,384,526) $ (4,211,621) $ (19,775,602) $ 593,905
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Depreciation and amortization 298,805 456,681    
Stock based compensation 2,088,838    
Equity compensation expense for services 1,726,000    
Change in fair value of derivative liabilities (24,017,035) 18,483,096
Loss on issuance of common stock and warrants 27,475,797    
Change in fair value of over-allotment liability     (19,432)
Changes in operating assets and liabilities:        
Accounts receivable 1,165 (76)    
Other receivable (115,000) (187,500)    
Inventory (1,700)    
Prepaid expenses 46,492 (11,700)    
Other current assets (356,301)    
Accounts payable and accrued expenses 1,560,273 (43,865)    
Due to related party 699,134    
Net Cash Used In Operating Activities (5,677,192) (3,298,947)    
Cash Flows From Investing Activities:        
Capitalized patent costs (190,931) (301,528)    
Net Cash Used In Investing Activities (190,931) (301,528)    
Cash Flows From Financing Activities:        
Capital contributions from Global Graphene Group 487,273 2,980,851    
Cash received from NUBI Trust 25,160,047    
Less discount payment related to Non Redemption Agreement (13,937,997)    
Less payment for reimbursement of consideration shares related to the Forward Purchase Agreement payment (2,193,800)    
Less reimbursement for Recycled Shares related to Forward Purchase Agreement (80,241)    
Less transaction expenses in connection with the Merger (8,948,009)    
Inflow from Merger 17,555    
Proceeds from convertible notes 527,500    
Proceeds from short-term notes 670,000    
Repayment of short term notes (1,329,712)    
Proceeds from issuance of common stock and warrants in connection with Private Placement 7,850,000    
Proceeds from issuance of common stock from exercise of warrants 163,974    
Issuance costs in connection with Private Placement (419,499)    
Repayment of related party payable (911,091)    
Net Cash Provided By Financing Activities 7,056,000 2,980,851    
Net change in cash 1,187,877 (619,624)    
Cash at beginning of period 780 621,575 621,575  
Cash at end of period 1,188,657 1,951 780 621,575
Supplemental disclosure        
Cash paid for interest expense 153,128    
Supplemental disclosure of non-cash financing activities:        
Issuance of Common Stock upon the closing of the Merger 2,435    
Previously Reported        
Cash Flows From Operating Activities:        
Net income (loss)     (19,775,602) 593,905
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Income earned on Investments held in Trust Account     (3,788,143) (1,812,882)
Change in fair value of over-allotment liability     (19,432)
Derivative asset/liabilities     18,483,096
Changes in operating assets and liabilities:        
Prepaid expenses     130,090 (215,628)
Other assets     35,870 (35,870)
Accrued formation and offering costs     (5,000)
Income tax payable     566,664 339,899
Accounts payable and accrued expenses     1,691,932 424,906
Net Cash Used In Operating Activities     (2,661,093) (725,102)
Cash Flows From Investing Activities:        
Cash withdrawn for taxes     1,523,258
Cash withdrawn for redemptions of Class Common Stock     89,038,494
Cash deposited into Trust Account     (1,985,000) (125,970,000)
Net Cash Used In Investing Activities     88,576,752 (125,970,000)
Cash Flows From Financing Activities:        
Proceeds from convertible note – Sponsor     1,172,159
Proceeds from convertible notes     905,000
Advances from Related Party     332,500
Advances from Target     187,500
Payments for redemption of Class A Common Stock     (89,038,494)
Sale of Units in the Initial Public Offering, net of underwriting discount     123,500,000
Issuance costs in connection with Private Placement     5,405,000
Payment of underwriter fees     (1,235,000)
Payment of offering costs     (429,243)
Net Cash Provided By Financing Activities     (86,441,335) 127,240,757
Net change in cash     (525,676) 545,655
Cash at beginning of period $ 19,979 $ 545,655 545,655
Cash at end of period     19,979 545,655
Supplemental disclosure        
Cash paid for income taxes     1,012,944
Supplemental disclosure of non-cash financing activities:        
Deferred offering costs included in accrued offering costs     25,000
Deferred offering costs included in related party payable     939
Deferred underwriters’ compensation charged to temporary equity in connection with the Public Offering     4,322,500
Class A redeemable Common Stock measurement adjustment at Initial Public Offering     12,942,102
Fair value of representative shares     776,815
Issuance of Common Stock upon the closing of the Merger     19,432
Excise tax on redemption of Class A Common Stock     890,385
Class A Common Stock Redeemable Current Period Remeasurement Adjustment     3,972,489 1,272,983
Reclassification of redeemed Class A ordinary shares     $ 17,834,235